Biotech & Drug DiscoveryKONEX 327610

Femtobiomed Inc.

Femtobiomed develops CellShot, a microfluidic non-viral electroporation gene-delivery platform for cell and gene therapy.

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded 2011, listed on KONEX in 2019, Femtobiomed develops a non-viral gene delivery platform for cell and gene therapy. Core products: the CellShot system (BADGER series, MENORAH-7000) using microfluidic electroporation, plus CellShot Cartridges, Proliva Buffer, and Cryoliva solution. It completed FDA DMF registration for CellShot Badger in August 2024, supplying pharma and CDMO clients.

Products & technology

CellShot System (BADGER series, MENORAH-7000)Device delivering mRNA, DNA, and other genetic material into cells via microfluidic continuous-flow electroporation
CellShot CartridgeConsumable microfluidic chip cartridge used with the CellShot system
Proliva Buffer / Cryoliva Freezing SolutionDedicated buffer for the electroporation process and a low-DMSO cell cryopreservation solution
SmartDropAnalytical instrument measuring fluid surface tension, solid contact angle, and solid surface energy

R&D and key agreements

Source: DART corporate disclosure

CellShot® Badger FDA DMF 등록 · 등록완료 · Completed DMF (Drug Master File) registration with the U.S. FDA for the CellShot Badger device in August 2024

Not yet compiled: business overview · regulatory approvals. Send us materials and we will add them

Companies in the same categoryBiotech & Drug Discovery

AHNLAB,INC.100

KOSDAQ-listed integrated security company behind the V3 antivirus and AhnLab TrusGuard and XDR solutions.

ORGANOIDSCIENCES LTD.100

Organoid-based biotech founded 2018, KOSDAQ-listed 2025, developing the ATORM-C regenerative therapeutic and ODISEI evaluation solution.

CG Invites Co., Ltd.85

Genomics and drug developer behind the osteoarthritis drug Acelex and the AI-driven healthcare platform Invites Loop.

Eone Diagnomics Genome Center Co., Ltd.85

EDGC, a Korea-US joint venture of Eone Medical Foundation and Diagnomics, offers the NIPT service NICE and liquid biopsy OncoCatch.

SK Chemicals Co., Ltd.85

A diversified SK group company operating eco-friendly chemical materials alongside pharmaceutical products like Joins and vaccines through subsidiary SK Bioscience.

ABION Inc.85

KOSDAQ-listed biotech developing biomarker-driven targeted cancer therapies including lead candidate Vabametkib (ABN401).

Y-Biologics, Inc85

KOSDAQ-listed antibody biotech developing the next-generation immuno-oncology candidate Multi-AbKine on its fully human antibody library Ymax®-ABL.

ProGen, Co,, LTD.85

KONEX-listed biotech venture developing new drug candidates with its multi-target fusion protein platform NTIG®

GI Innovation Inc.85

Biotech company developing fusion-protein immuno-oncology and allergy therapeutics, listed on KOSDAQ since 2023.

SillaJen, Inc.85

SillaJen, Inc., founded in 2006 and listed on KOSDAQ in 2016, develops the oncolytic virus immunotherapy Pexa-Vec.

SK Bioscience Co.,Ltd84

A vaccine specialist developing in-house products such as SKYCellflu and SKYZoster while also serving as CDMO for AstraZeneca and Novavax.

LigaChem Biosciences Inc.83

An ADC (antibody-drug conjugate) developer with its ConjuALL platform, having licensed pipeline assets to Janssen, Ono Pharmaceutical, and other global partners.

Sources and updates

Company basics: Korea Exchange · DART
Business content: Compiled from disclosure filings
AI visibility: Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition